Literature DB >> 18392350

[Historical evolution of package inserts in Brazil].

Telma Rodrigues Caldeira1, Eugênio Rodrigo Zimmer Neves, Edson Perini.   

Abstract

In Brazil, package inserts provide key information on pharmaceuticals. The current study analyzes the evolution of package inserts and the impact on this process by scientific research and development, globalization of information, and various health policies. The study began with a retrospective review of Brazilian health legislation until 1920, the year when the National Public Health Department was created. The analysis of documents on the evolution of health regulation in Brazil began with the Brazilian Pharmaceutical Collection-Health Rulings. The second stage of the study involved a search of standards and norms in VISALEGIS: Health Surveillance Legislation, Portal for Legislation from the National Congressional Information System and the Health Legislation System. Package inserts became an important vehicle for information in the country and underwent important regulatory changes in the latter half of the 20th century. From 1946 to 2006, the number of mandatory items increased, with more in-depth description. However, the standardization of information for medicines with the same active ingredient failed to materialize, despite its importance and the various legal initiatives in this direction.

Mesh:

Year:  2008        PMID: 18392350     DOI: 10.1590/s0102-311x2008000400003

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Quality of clinical studies present in the package inserts of coagulation factors used in the treatment of hemophilia.

Authors:  Yasmin Gonçalves Araújo; João Pedro Vasconcelos Paolinelli; Janaina Souza Dias Pichitelli; Danyelle Romana Alves Rios; Nayara Ragi Baldoni; André Oliveira Baldoni
Journal:  Einstein (Sao Paulo)       Date:  2022-05-06

Review 2.  Regulation of Drug Prescribing Information in Latin America and the Caribbean.

Authors:  Mariana Ramírez-Telles; Urimara Argotti-Rodríguez
Journal:  Ther Innov Regul Sci       Date:  2022-04-05       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.